Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 – 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.

What were the topic/research questions being investigated? How was the study conducted (participants, materials, procedure, etc.)? What did the results reveal? How might these methodological considerations affect the research findings and the conclusions drawn from them?
September 13, 2020
Describe the products (goods and services) that interest these youth markets. Compare and contrast the micro and macro-environmental forces that can influence the marketing strategies for these products (goods and services). Analyze the marketing strategies of these two countries and compare them with Western-based consumption marketers (e.g., US)
September 13, 2020

Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 – 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.

MGT-325   Discussion # 1   Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 – 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.   XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX   Discussion #2   Given your answer to Discussion Forum 1, discuss in 200 – 250 words what you believe Young Again Pharmaceuticals should focus on once the risks are mitigated.   If you need a copy of the Case 9-1 I can forward to you

MGT-325

 

Discussion # 1

 

Case 9-1 discusses Young Again Pharmaceuticals. The three options that this firm has to manage risk are risk retention, risk transfer, or a mixed approach. In 200 – 250 words, discuss your recommendations on how this company should evaluate and implement these techniques to manage risks.

 

XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX

 

Discussion #2

 

Given your answer to Discussion Forum 1, discuss in 200 – 250 words what you believe Young Again Pharmaceuticals should focus on once the risks are mitigated.

 

If you need a copy of the Case 9-1 I can forward to you


PLACE THIS ORDER OR A SIMILAR ORDER AND GET HELP FROM A CERTIFIED WRITER:)

Click the button below to order this paper AND ENJOY OUR DISCOUNT.

E
E

Comments are closed.